Pilato Andrea, D'Avanzo Giorgio, Di Nunzio Francesca, Marino Annalisa, Gallo Alessia, Genovali Irene, Di Corcia Letizia Pia, Taffon Chiara, Perrone Giuseppe, Liakouli Vasiliki, Navarini Luca, Giacomelli Roberto, Berardicurti Onorina, Antonelli Incalzi Raffaele
Clinical Unit of Immunorheumatology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Roma, Italy.
Research Unit of Immunorheumatology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 200, 00128 Roma, Italy.
J Clin Med. 2025 Jul 31;14(15):5395. doi: 10.3390/jcm14155395.
: Anti-synthetase Syndrome (ASyS) is an idiopathic inflammatory myopathy characterized by muscle weakness and inflammatory infiltrates in muscles. Sjogren's disease (SD) is an autoimmune condition primarily affecting exocrine glands. Both these conditions may present lung involvement. We describe a female patient with anti-synthetase/SD overlap syndrome and review the literature to identify published cases describing this overlap, aiming to better define its clinical, radiological, and serological features. : The case description was based on a retrospective collection of clinical, laboratory, and imaging data related to the patient's diagnostic process and clinical course. Data were anonymized and handled in accordance with the competent territorial Ethics Committee. A literature review was performed using the MEDLINE and Scopus databases by combining the keywords "Anti-Synthetase syndrome", "Sjögren disease", "Sjögren syndrome", "Myositis", and "Interstitial lung disease" (ILD). Published cases were selected if they met the 2016 EULAR/ACR criteria for SD and at least one of the currently proposed classification criteria for ASyS. : The described case concerns a 68-year-old woman with rapidly progressive ILD. The diagnosis of anti-synthetase/SD overlap syndrome was based on clinical, serological (anti-Ro52 and anti-PL7 antibodies), histological, and radiological findings. Despite immunosuppressive and antifibrotic treatment, the clinical course worsened, leading to a poor outcome. In addition, six relevant cases were identified in the literature. Clinical presentations, autoantibody profiles, radiological findings, and outcomes were highly heterogeneous. Among the reported cases, no standardized treatment protocols were adopted, reflecting the lack of consensus in managing this rare condition. : In anti-synthetase/SD overlap syndrome, ILD may follow a rapidly progressive course. Early recognition can be challenging, especially in the absence of muscular involvement. This case-based review highlights the need for more standardized approaches to the diagnosis and management of this rare and complex overlap syndrome.
抗合成酶综合征(ASyS)是一种特发性炎性肌病,其特征为肌肉无力和肌肉炎性浸润。干燥综合征(SD)是一种主要累及外分泌腺的自身免疫性疾病。这两种疾病均可出现肺部受累。我们报告一例抗合成酶/干燥综合征重叠综合征的女性患者,并回顾文献以识别描述这种重叠情况的已发表病例,旨在更好地明确其临床、影像学和血清学特征。:病例描述基于回顾性收集与患者诊断过程和临床病程相关的临床、实验室及影像学数据。数据进行了匿名处理,并按照主管地区伦理委员会的要求进行处理。通过结合关键词“抗合成酶综合征”“干燥病”“干燥综合征”“肌炎”和“间质性肺病”(ILD),使用MEDLINE和Scopus数据库进行文献回顾。如果已发表病例符合2016年欧洲抗风湿病联盟/美国风湿病学会(EULAR/ACR)干燥综合征标准以及目前提出的抗合成酶综合征分类标准中的至少一项,则将其纳入。:所描述的病例为一名68岁患有快速进展性ILD的女性。抗合成酶/干燥综合征重叠综合征的诊断基于临床、血清学(抗Ro52和抗PL7抗体)、组织学及影像学检查结果。尽管进行了免疫抑制和抗纤维化治疗,但临床病程仍恶化,导致预后不良。此外,在文献中还识别出6例相关病例。临床表现、自身抗体谱、影像学检查结果及预后高度异质性。在所报告的病例中,未采用标准化治疗方案,这反映出在管理这种罕见疾病方面缺乏共识。:在抗合成酶/干燥综合征重叠综合征中,ILD可能呈快速进展病程。早期识别可能具有挑战性,尤其是在无肌肉受累的情况下。基于病例的回顾强调了对这种罕见且复杂的重叠综合征的诊断和管理需要更标准化的方法。